Publication: 7

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
      QxMD      Google Scholar   
Citation:
Ann Oncol vol 21 (2) 269-274
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
CA25224  
Corr. Author:
 
Authors:
                           
Networks:
 
Study
NCCTG-N0432
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
bevacizumab, capecitabine, chemotherapy, docetaxel